FTFinancial Times·14hBusiness
score-0.40
Novartis Shares Slide as Muscular Disease Trial Ends; Swiss Maker Faces Pipeline Setback
Original
Novartis shares slide after drug for muscular disease fails trial
“Uses financial terms like 'slide' and 'setback' to describe a corporate business loss without invoking patient suffering.”